Skip to main content
Full access
Case Reports
Published Online: 18 September 2019

Koro Delusion in Mild Cognitive Impairment Due to Alzheimer’s Disease

Publication: The Journal of Neuropsychiatry and Clinical Neurosciences
While neuropsychiatric symptoms have been well-recognized complications of Alzheimer’s disease in advanced stages of dementia, there is increasing interest in the characterization of these symptoms in early stages, such as mild cognitive impairment (1, 2). Neuropsychiatric symptoms in mild cognitive impairment not only add to the distress of cognitive deficits but also may delineate subgroups of patients who are at higher risk for conversion to dementia (3). Numerous studies have shown that in mild cognitive impairment, the predominant neuropsychiatric symptoms can include depression, anxiety, and apathy (1, 4). Psychotic symptoms (delusions and hallucinations) typically manifest in the dementia stages (2), with studies suggesting a direct correlation between the severity of the dementia and emergence of psychotic symptoms (4). Indeed, the incidence rate of psychotic symptoms in mild cognitive impairment is fairly low, estimated to be between 3% and 14% (5). Similarly, prevalence rates range between 1% and 10% (6). The most common psychotic symptoms observed are persecutory delusions, delusional misidentifications, and visual hallucinations, although prominent psychosis early in the disease course may in fact be more suggestive of incipient Lewy body disease rather than Alzheimer’s disease (7).
Koro delusion, which is not explicitly described in DSM-5 but was included in DSM-IV, has been previously defined as having a “sudden and intense anxiety that the penis will recede into the body and possibly cause death” (8). Phenomenologically, this syndrome was previously described as a culture-bound syndrome, geographically localized to Southeast Asia, Japan, and China, although in the past few decades, the syndrome has been reframed to include both a culture-bound epidemic form and a nonculturally bound isolated form (9). The isolated form has been described in numerous case reports around the world and generally understood to manifest in the context of broader underlying psychiatric pathologies, including body dysmorphic disorders, anxiety and panic disorders, somatoform disorders, dissociative and depersonalization disorders, and psychotic depression or, in the psychoanalytic arena, as a form of castration anxiety (1013).
There have been few reports of Koro occurring in settings of nonpurely psychiatric conditions, that is, following some form of a direct physiologic insult, such as after a stroke (14), in the setting of alcoholic hepatitis (15), after abrupt withdrawal of an antipsychotic medication (16), in the setting of a tumor of the corpus callosum (17), in bronchial carcinoma with metastatic spread to the CNS (18), and in the setting of abnormal epileptic activity (19). For cases with direct CNS involvement, localization studies are limited but highlight the right temporoparietal lobes (14), the genu of the corpus callosum (17), the left frontotemporal lobe (18), and the bitemporoparietal region (19). Importantly, to the best of our knowledge, there are no reports of this delusion in the setting of age-related neurodegenerative disease. Here, we present the first reported case of Koro syndrome presenting in mild cognitive impairment as a result of Alzheimer’s disease.

Case Report

A 78-year-old man was initially evaluated after being referred by his primary care physician for memory loss spanning more than 1 year. His medical history was notable for a minor stroke many years prior (which resulted in vision loss that was resolved). His evaluation at the memory disorders clinic revealed mild errors in recall, as well as deficits in visuoconstruction, and his score on the Mini-Mental State Examination (MMSE) was 27/30. This corresponded to a Z score of –0.869 (based on sex, age, and 12 years of education) (20). There were no signs or symptoms of parkinsonism. The patient reported independence in all of his activities of daily living as well as instrumental activities of daily living, which was corroborated by interview with a family member at a later date, and he was living alone. From this initial evaluation, he did not meet criteria for mild cognitive impairment (21), but an initial workup was recommended. Reversible dementia studies revealed normal B12 and thyroid-stimulating hormone levels. A brain MRI was ordered but not initially completed. A follow-up clinical evaluation 5 months later revealed mostly stable findings. Three months later, at a routine visit with his primary care physician, the patient complained that he “heard his penis shrink” and that it had “retracted.” This was causing him a great deal of anxiety. Physical examination of the penis revealed no abnormalities. The patient also reported deleting an e-mail that he had written to his primary care physician after hearing a voice emanating from a computer screen, associated with an incessant “banging” noise. Word-finding difficulty was also noted. The patient was once again evaluated at the memory disorders clinic, where he was seen urgently and reiterated that his penis had physically shrunk, despite knowledge of a normal clinical examination, although he was less anxious about the situation. He was apologetic about “bothering” his primary care physician and showed the neurologist letters of apology that he had written to his physician. There was some delusional content surrounding these letters, because he reported that the letters were “speaking” to him. A neurologic examination at this visit to the memory disorders clinic revealed mild deficits in registration, recall, and attention and concentration, but the patient’s visuospatial construction had improved. Now at age 79, his MMSE score was 24/30, which corresponded to a Z score of –3.274 (20). He remained functionally independent, which was corroborated by family members, and thus he met criteria for mild cognitive impairment (21). Brain MRI was completed and revealed mild supratentorial white matter changes suggestive of microvascular disease and mild bitemporal volume loss suggestive of Alzheimer’s disease (Figure 1A and B). Fluorodeoxyglucose positron emission tomography (FDG-PET) showed decreased uptake in bilateral parietal and temporal lobes, consistent with Alzheimer’s disease (Figure 1C and D).
FIGURE 1. Structural and functional imaging consistent with Alzheimer’s disease in a patient with mild cognitive impairment and Koro delusiona
a The axial fluid-attenuated inversion recovery MRI shows mild periventricular and subcortical white matter hyperintensities (panel A) and mild hippocampal atrophy (panel B). On axial view, fluorodeoxyglucose positron emission tomography computerized tomography reveals parietal (panel C) and temporal (panel D) hypometabolism.

Discussion

The above case is, to our knowledge, the first reported case of Koro syndrome manifesting in a patient with mild cognitive impairment as a result of Alzheimer’s disease. The rarity of this presentation is multifactorial. Patients with mild cognitive impairment have a decreased frequency and severity of neuropsychiatric symptoms as part of their symptom complex compared with patients with major cognitive disorder or dementia (22). Of the neuropsychiatric symptoms that do manifest in mild cognitive impairment, psychotic symptoms are less frequently observed compared with the more common symptoms of apathy, irritability, depression, and anxiety (1, 4, 6), and of the psychotic manifestations that are observed in patients with mild cognitive impairment, Koro syndrome is uncommon.
When considering the typical psychotic presentations among patients with mild cognitive impairment or Alzheimer’s disease, delusions of misidentification or persecution (which, it can be argued, are deeply interrelated) are the most commonly seen (23). Delusional misidentification has been typically localized to the right hemisphere, especially the right frontal lobes (24). Delusions of body image, under which Koro syndrome has been previously categorized, have also been attributed to right-hemisphere pathology, given the right hemisphere’s “role in the construction of the corporeal and psychological self” (25). Gurin and Blum (26) extensively described the relationship of the right hemisphere and delusion formation, essentially assigning four fundamental roles employed by the right hemisphere that afford an individual the “ability to create and maintain accurate appraisals of mental objects holistically and in context—be they simple visuospatial figures, complex narratives, or the self,” the loss of any one of which allows for the eventual formation of delusional content. While no clear area of localization has previously been attributed to the development of Koro syndrome, the few reported cases involving organic CNS lesions appear to suggest temporal lobe involvement, as delineated in the above case.
Why our patient developed this particular delusional syndrome is unclear. His FDG-PET revealed bitemporal hypometabolism, although this is a common finding in patients with Alzheimer’s disease at the mild cognitive impairment stage, most of whom do not have Koro delusion. Psychosis is more apparent in early stages of Lewy body dementia, although our patient’s FDG-PET did not show the occipital involvement that is often associated with this neurodegenerative condition. Furthermore, our patient did not present with other symptoms, such as parkinsonism, fluctuation, or dysautonomia. Delusions can be prominent early in frontotemporal dementia associated with the C9ORF72 mutation, which is thought to localize to frontal disease that was not apparent in our patient (27). Although isolated Koro has been classically conceptualized as a form of body dysmorphic disorder or depersonalization, perhaps it can be viewed in the context of delusional misidentification, though in this setting it is a misidentification of the self. Such a framework would make Koro delusion in a patient with Alzheimer’s disease with mild cognitive impairment more understandable, if not at least less unusual. Similarly, the associated symptoms of anxiety and panic in this syndrome can be interpreted as a manifestation of underlying paranoid obsession with the loss of the self or, alternatively, with one’s inevitable demise.
Beyond etiopathology or nosology, from a clinical standpoint, it is evident from this case that, as previously suggested by Anderson (14), Koro delusion itself should be understood as a symptom of a likely larger underlying insult, in our patient occurring as part of the symptom complex of mild cognitive impairment in Alzheimer’s disease. And, as demonstrated in the above case, regardless of the nosology and etiopathology of Koro delusion, the detection of underlying neuropsychiatric symptoms in patients with mild cognitive impairment, including the less common manifestation of delusions and hallucinations, plays an important prognostic role, given the greater risk of progression to dementia (1).

Acknowledgments

The authors have confirmed that details of the case have been disguised to protect patient privacy.

References

1.
Rosenberg PB, Mielke MM, Appleby BS, et al: The association of neuropsychiatric symptoms in MCI with incident dementia and Alzheimer disease. Am J Geriatr Psychiatry 2013; 21:685–695
2.
Weamer EA, DeMichele-Sweet MA, Cloonan YK, et al: Incident psychosis in subjects with mild cognitive impairment or Alzheimer’s disease. J Clin Psychiatry 2016; 77:e1564–e1569
3.
Taragano FE, Allegri RF, Heisecke SL, et al: Risk of conversion to dementia in a mild behavioral impairment group compared to a psychiatric group and to a mild cognitive impairment group. J Alzheimers Dis 2018; 62:227–238
4.
Siafarikas N, Selbaek G, Fladby T, et al: Frequency and subgroups of neuropsychiatric symptoms in mild cognitive impairment and different stages of dementia in Alzheimer’s disease. Int Psychogeriatr 2018; 30:103–113
5.
Monastero R, Mangialasche F, Camarda C, et al: A systematic review of neuropsychiatric symptoms in mild cognitive impairment. J Alzheimers Dis 2009; 18:11–30
6.
Apostolova LG, Cummings JL: Neuropsychiatric manifestations in mild cognitive impairment: a systematic review of the literature. Dement Geriatr Cogn Disord 2008; 25:115–126
7.
McKeith IG, Boeve BF, Dickson DW, et al: Diagnosis and management of dementia with Lewy bodies: fourth consensus report of the DLB Consortium. Neurology 2017; 89:88–100
8.
American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 4th ed. Washington, DC, American Psychiatric Association, 1994
9.
Buckle C, Chuah YM, Fones CS, et al: A conceptual history of Koro. Transcult Psychiatry 2007; 44:27–43
10.
Yap PM: Koro: a culture-bound depersonalization syndrome. Br J Psychiatry 1965; 111:43–50
11.
Bernstein RL, Gaw AC: Koro: proposed classification for DSM-IV. Am J Psychiatry 1990; 147:1670–1674
12.
Cheng ST: Epidemic genital retraction syndrome: environmental and personal risk factors in southern China. J Psychol Human Sex 1997; 9:57–70
13.
Phillips KA, Wilhelm S, Koran LM, et al: Body dysmorphic disorder: some key issues for DSM-V. Depress Anxiety 2010; 27:573–591
14.
Anderson DN: Koro: the genital retraction symptom after stroke. Br J Psychiatry 1990; 157:142–144
15.
Holden TJ: Koro syndrome associated with alcohol-induced systemic disease in a Zulu. Br J Psychiatry 1987; 151:695–697
16.
Ramos RH, Budman CL: Emergence of Koro after abrupt cessation of olanzapine. J Clin Psychiatry 1998; 59:86–87
17.
Durst R, Rosca-Rebaudengo P: Koro secondary to a tumour of the corpus callosum. Br J Psychiatry 1988; 153:251–254
18.
Lapierre YD: Koro in a French Canadian. Can Psychiatr Assoc J 1972; 17:333–334
19.
Joseph AB: Koro: computed tomography and brain electrical activity mapping in two patients. J Clin Psychiatry 1986; 47:430–432
20.
Shirk SD, Mitchell MB, Shaughnessy LW, et al: A web-based normative calculator for the uniform data set (UDS) neuropsychological test battery. Alzheimers Res Ther 2011; 3:32
21.
Albert MS, DeKosky ST, Dickson D, et al: The diagnosis of mild cognitive impairment due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement 2011; 7:270–279
22.
Lopez OL, Becker JT, Sweet RA, et al: Psychiatric symptoms vary with the severity of dementia in probable Alzheimer’s disease. J Neuropsychiatry Clin Neurosci 2003; 15:346–353
23.
Rubin EH, Drevets WC, Burke WJ: The nature of psychotic symptoms in senile dementia of the Alzheimer type. J Geriatr Psychiatry Neurol 1988; 1:16–20
24.
Darby R, Prasad S: Lesion-related delusional misidentification syndromes: a comprehensive review of reported cases. J Neuropsychiatry Clin Neurosci 2016; 28:217–222
25.
Devinsky O: Right cerebral hemisphere dominance for a sense of corporeal and emotional self. Epilepsy Behav 2000; 1:60–73
26.
Gurin L, Blum S: Delusions and the right hemisphere: a review of the case for the right hemisphere as a mediator of reality-based belief. J Neuropsychiatry Clin Neurosci 2017; 29:225–235
27.
Sellami L, Bocchetta M, Masellis M, et al: Genetic FTD Initiative, GENFI: Distinct neuroanatomical correlates of neuropsychiatric symptoms in the three main forms of genetic frontotemporal dementia in the GENFI cohort. J Alzheimers Dis 2018; 65:147–163

Information & Authors

Information

Published In

Go to The Journal of Neuropsychiatry and Clinical Neurosciences
Go to The Journal of Neuropsychiatry and Clinical Neurosciences
The Journal of Neuropsychiatry and Clinical Neurosciences
Pages: 204 - 206
PubMed: 31530117

History

Received: 6 May 2019
Revision received: 17 July 2019
Accepted: 29 July 2019
Published online: 18 September 2019
Published in print: Spring 2020

Keywords

  1. Delusion
  2. Alzheimer’s Disease
  3. Psychosis

Authors

Details

Michael Tau, M.D.
The Department of Neurology, New York University Langone Health, New York (Tau, Masurkar); the Department of Neuroscience and Physiology, New York University Langone Health, New York (Masurkar); and the Center for Cognitive Neurology, New York University Langone Health, New York (Masurkar).
Arjun V. Masurkar, M.D., Ph.D. [email protected]
The Department of Neurology, New York University Langone Health, New York (Tau, Masurkar); the Department of Neuroscience and Physiology, New York University Langone Health, New York (Masurkar); and the Center for Cognitive Neurology, New York University Langone Health, New York (Masurkar).

Notes

Send correspondence to Dr. Masurkar ([email protected]).

Funding Information

The authors report no financial relationships with commercial interests.

Metrics & Citations

Metrics

Citations

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format
Citation style
Style
Copy to clipboard

View Options

View options

PDF/EPUB

View PDF/EPUB

Login options

Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.

Personal login Institutional Login Open Athens login
Purchase Options

Purchase this article to access the full text.

PPV Articles - Journal of Neuropsychiatry and Clinical Neurosciences

PPV Articles - Journal of Neuropsychiatry and Clinical Neurosciences

Not a subscriber?

Subscribe Now / Learn More

PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Media

Figures

Other

Tables

Share

Share

Share article link

Share